Author: Victoria Dekker

Psychedelics Today, an education company, will soon be launching an in-depth, 12-month training focused on psychedelic therapy and integration.

“In the current marketplace, there’s actually a gap,” the company’s director of operations and strategic growth, David Drapkin, told Fierce Healthcare. Demand for psychedelic therapy is thriving, but the field remains available primarily only to clinicians. As a result, many are giving therapy in an unregulated space.

Click here to read more.

According to Psychedelics Today podcast co-founder and CEO Joe Moore, many “classical psychedelics” have been available in the West for decades, largely illegally and for recreational use. These include:

– psilocybin (magic mushrooms)
– DMT
– lysergic acid (LSD or acid)
– mescaline (peyote)

“Many more have been developed since, and many more are still being developed for assorted medical indications,” Moore adds.

“We don’t yet have a full grasp of this on account of prohibition and inappropriate barriers to research,” says Moore. “What we do know is that at the very least, the mind is distributed through the body.”

Catch more of the interview with Joe in this Healthline article.

Click here to read more.

Psychedelics have been used as religious, medicinal, and wellness tools in many cultures and parts of the world for centuries. But in recent years, researchers have been studying the potential healing properties of these substances for mental health conditions. 

Although clinical studies on the therapeutic use of psychedelics are still underway, current research suggests that they may be able to help treat certain mental health conditions, like depression and PTSD, and improve overall mental health. 

This fascinating alternative practice is known as psychedelic-assisted psychotherapy (PAP), or psychedelic therapy.

“Psychedelic therapy is the process of taking a psychedelic substance within a therapeutic setting, which typically includes psychotherapy,” explains Kyle Buller, MS, cofounder and director of training and clinical education at Psychedelics Today.

Catch more from Kyle in this interview with PsychCentral.

Click here to read more.

Psychedelic microdosing has exploded in popularity in recent years, with a noticeable uptick during the COVID-19 pandemic. Research is exploring the possible mental health effects of microdosing.

Read some thoughts from Psychedelics Today CEO Joe Moore on microdosing in this article from PsychCentral.

Click here to read more.